Sanliurfa Education and Research Hospital
Sanliurfa, Şanlıurfa, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT07520734
This single-center prospective observational study aims to evaluate clinical outcomes, postoperative pain scores, complications, and patient satisfaction in adults undergoing laser hemorrhoidoplasty for symptomatic internal hemorrhoidal disease. Additional objectives are to assess the relationship between hemorrhoid stage, dominant presenting symptoms, operative technical details, and postoperative outcomes. No study-specific intervention beyond routine clinical care and follow-up will be performed.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Sanliurfa, Şanlıurfa, Turkey (Türkiye)
Location status: Recruiting
Hemorrhoidal disease is a common benign anorectal condition that can significantly impair quality of life. Conventional excisional techniques may be associated with postoperative pain, bleeding, prolonged recovery, and lower patient satisfaction. Laser hemorrhoidoplasty is a minimally invasive technique based on coagulation and shrinkage of hemorrhoidal tissue without excision. This prospective observational study will be conducted at the General Surgery Clinic of Sanliurfa Education and Research Hospital. Adult patients with symptomatic internal hemorrhoidal disease who are scheduled to undergo laser hemorrhoidoplasty will be enrolled. Preoperative symptoms, hemorrhoid stage, and physical examination findings will be recorded. Intraoperative data will include laser wavelength, total delivered energy, number of hemorrhoidal packages treated, and any additional surgical procedures. Postoperative pain will be assessed at predefined time points using the Visual Analog Scale. Analgesic requirement and duration, length of hospital stay, time to return to daily activities, early complications within 30 days, late complications, symptom status, and recurrence at 6 months will be documented. The study is designed to clarify the clinical role of laser hemorrhoidoplasty and help define appropriate patient selection criteria.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Laser-based minimally invasive treatment of internal hemorrhoidal disease performed as part of routine clinical care.
Time frame: At 6 hours, 24 hours, and 1 week after surgery
Postoperative pain assessed using a 0 to 10 Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain; higher scores indicate worse pain.
Time frame: From the day of surgery through 30 days after surgery
Duration of postoperative analgesic use, measured in days.
Time frame: From the day of surgery to hospital discharge, up to 7 days
Postoperative hospital stay, measured in days from the date of surgery to the date of discharge.
Time frame: Within 30 days after surgery
Number and proportion of patients who develop any predefined early postoperative complication within 30 days after laser hemorrhoidoplasty. Predefined complications include postoperative bleeding, urinary retention, anal thrombosis, infection, severe pain, and anal stenosis. Patients without any of these events will be classified as having no complication.
Time frame: Up to 30 days after surgery
Time required to return to usual daily activities, measured in days.
Time frame: Up to 3 months after surgery
Patient-reported satisfaction after laser hemorrhoidoplasty.
Contact information is provided by the study sponsor or research team.
Sanliurfa Education and Research Hospital
Other Gov
Clinical Outcomes, Pain Scores, and Patient Satisfaction in Patients Undergoing Laser Hemorrhoidoplasty: A Prospective Observational Study
Acronym: LHP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07666035
Chronic Anal Fissure, Cryptoglandular Anal Fistula
View Trial DetailsNCT07669662
Cardiovascular Diseases, Digestive System Diseases
Bursa, Turkey (Türkiye)
View Trial DetailsNCT07587892
Cardiovascular Diseases, Digestive System Diseases
Moscow, Russia
View Trial DetailsNCT02303925
Hemorrhoidal Disease
Marseille, France
View Trial Details